IP Verse

New Avv Capsid Proteins For Nucleic Acid Transfer - EP3147295

The patent EP3147295 was granted to The Board OF Trustees OF The Leland Stanford Junior University on Nov 22, 2023. The application was originally filed on Aug 24, 2012 under application number EP16196258A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3147295

THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Application Number
EP16196258A
Filing Date
Aug 24, 2012
Status
Patent Maintained As Amended
Oct 20, 2023
Grant Date
Nov 22, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

EUROPEAN OPPOSITIONSSep 9, 2021KILBURN & STRODEADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2010047174
EXAMINATIONUS7749492
OPPOSITIONLK03
OPPOSITIONUS6156303
OPPOSITIONUS7749492
SEARCHEP2298926
SEARCHUS2010047174

Non-Patent Literature (NPL) Citations (41) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ALTSCHUL ET AL., J. MOL. BIOL., (1990), vol. 215, pages 403 - 410-
DESCRIPTION- ALTSCHUL ET AL., NUCLEIC ACIDS RES., (1997), vol. 25, pages 3389 - 3402-
DESCRIPTION- AZUMA ET AL., NATURE BIOTECH., (2007), vol. 25, pages 903 - 910-
DESCRIPTION- CRAMERI, NATURE, (1998), vol. 391, pages 288 - 291-
DESCRIPTION- GAO, G. ET AL., J. VIROL., (2004), vol. 78, pages 6381 - 6388-
DESCRIPTION- GRIMM, D. ET AL., BLOOD, (2003), vol. 102, pages 2412 - 2419-
DESCRIPTION- KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, pages 2264 - 2268-
DESCRIPTION- KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI.USA, (1993), vol. 90, pages 5873 - 5877-
DESCRIPTION- KERN, A. ET AL., J. VIROL., (2003), vol. 77, pages 11072 - 11081-
DESCRIPTION- LOGAN; SHENK, PROC. NATL. ACAD. SCI. USA, (1984), vol. 81, pages 3655 - 3659-
DESCRIPTION- MACKETT ET AL., J. VIROL., (1984), vol. 49, pages 857 - 864-
DESCRIPTION- MACKETT ET AL., PROC. NATL. ACAD. SCI. USA, (1982), vol. 79, pages 7415 - 7419-
DESCRIPTION- MANNO ET AL., NATURE MEDICINE, (2006), vol. 12, no. 3, page 342-
DESCRIPTION- PANICALI ET AL., PROC. NATL. ACAD. SCI. USA, (1982), vol. 79, pages 4927 - 4931-
DESCRIPTION- SUMMERFORD, C. ET AL., J. VIROL., (1998), vol. 72, pages 1438 - 1445-
DESCRIPTION- WOOTTON; FEDERHEN, COMPUTERS AND CHEMISTRY, (1993), vol. 17, pages 149 - 163-
EXAMINATION- FRENCH ET AL, J MOL EVOL, 1983, (1983), vol. 19, pages 171 - 175-
EXAMINATION- ZHANG, J MOL EVOL, (2000), vol. 50, pages 56 - 68-
OPPOSITION- Abstract for Oral Presentation given on 18 May 2022 - Gonzalez-Sandoval et al-
OPPOSITION- "BLAST alignment between AAV3B VP3 portion with SEQ ID NO : 31 from the opposed patent", BLAST, URL: ncbi-
OPPOSITION- Cabanes-Cresu et al., Molecular Therapy . Methods & Clinical Devel.,24. 88-101-
OPPOSITION- Cabanes-Creus et al Sci. Transl. Med., 12 : eaba3312-
OPPOSITION- Comparison of LK03 Nucleotide Sequence to Sequence 1-
OPPOSITION- Extracts from Oral Presentation given on 18 May 2022 by Gonzalez-Sandoval et al.-
OPPOSITION- Final experimental data-
OPPOSITION- George et al., New England Journal of Medicine. 385(21): 1961-1973-
OPPOSITION- Kay, MA. Molecular Therapy, 23(12)- 1800-1801-
OPPOSITION- Leszek Lisowski et al, "Selection and evaluation of clinically relevant AAV variants in a xenograft liver model", Nature, London, (20140201), vol. 506, no. 7488, pages 382 - 386-
OPPOSITION- Li et al, Molecular Therapy 23(12): 1867-1876-
OPPOSITION- Lili Wang et al, "Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids", Molecular Therapy, US, (20151201), vol. 23, no. 12, pages 1877 - 1887-
OPPOSITION- NCBI Blast, "Blast 3B to LK03 SID41*, cited 26 08 2021-
OPPOSITION- Paulk et al., Molecular Therapy, 26(1). 289-303-
OPPOSITION- Paulk et al., YMTHE, Volume 26, Supplemental Information -Bioengineered AAV Capsids with Combined High Human Liver Transduction in Vivo and Unique Humoral Seroreactivity-
OPPOSITION- Pekrun et al., JCI Insight, 4(22) ,e131610-
OPPOSITION- RUTLEDGE E. A. ET AL., "Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US, (19980101), vol. 72, no. 1, ISSN 0022-538X, pages 309 - 319, XP002137089-
OPPOSITION- RUTLEDGE E. A. ET AL., "Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.", Journal of Virology, US, (19980101), vol. 72, no. 1, pages 309 - 319-
OPPOSITION- Sumpter et al.. Journal Of Virology, March 2005, pages 2689-2699:Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase,RIG-1-
OPPOSITION- Wang Supplementary Materials-
OPPOSITION- Zou et al, Molecular Therapy: Methods & Clincal Development, 18:189-198-
OPPOSITION- Lili Wang, Peter Bell, Suryanarayan Somanathan, Qiang Wang, Zhenning He, Hongwei Yu, Deirdre Mcmenamin, Tamara Goode, Roberto Calcedo, James M Wilson, "Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids", Molecular Therapy, Elsevier Inc., US, US, (20151201), vol. 23, no. 12, doi:10.1038/mt.2015.179, ISSN 1525-0016, pages 1877 - 1887, XP055454604
OPPOSITION- Leszek Lisowski, Allison P. Dane, Kirk Chu, Yue Zhang, Sharon C. Cunningham, Elizabeth M. Wilson, Sean Nygaard, Markus Grompe, Ian E. Alexander, Mark A. Kay, "Selection and evaluation of clinically relevant AAV variants in a xenograft liver model", Nature, Macmillan Journals Ltd., etc., London, London, (20140201), vol. 506, no. 7488, doi:10.1038/nature12875, ISSN 0028-0836, pages 382 - 386, XP055573596

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents